|
PRKAB2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.995600E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.435200E-03 |
| Normal-vs-Stage2 |
9.922000E-01 |
| Normal-vs-Stage3 |
4.12859999998627E-06 |
| Normal-vs-Stage4 |
4.10740000011955E-07 |
| Stage1-vs-Stage2 |
1.855760E-01 |
| Stage1-vs-Stage3 |
6.164800E-03 |
| Stage1-vs-Stage4 |
1.544450E-03 |
| Stage2-vs-Stage3 |
2.110500E-02 |
| Stage2-vs-Stage4 |
9.923800E-03 |
| Stage3-vs-Stage4 |
5.157400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.427700E-04 |
| Normal-vs-AfricanAmerican |
4.25350000000657E-05 |
| Normal-vs-Asian |
6.010400E-01 |
| Caucasian-vs-AfricanAmerican |
6.717800E-02 |
| Caucasian-vs-Asian |
5.344000E-01 |
| AfricanAmerican-vs-Asian |
1.347000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.217400E-03 |
| Normal-vs-Female |
2.47469999999916E-05 |
| Male-vs-Female |
6.990100E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.523700E-02 |
| Normal-vs-Age(41-60Yrs) |
7.999400E-03 |
| Normal-vs-Age(61-80Yrs) |
4.03900000000013E-05 |
| Normal-vs-Age(81-100Yrs) |
2.208100E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.196600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.767400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.604000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.415700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.722600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.309400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
5.033600E-01 |
| Normal-vs-Grade 2 |
1.404470E-02 |
| Normal-vs-Grade 3 |
1.422420E-04 |
| Normal-vs-Grade 4 |
8.87689999284902E-09 |
| Grade 1-vs-Grade 2 |
6.443700E-02 |
| Grade 1-vs-Grade 3 |
3.607700E-02 |
| Grade 1-vs-Grade 4 |
2.411500E-04 |
| Grade 2-vs-Grade 3 |
5.476200E-02 |
| Grade 2-vs-Grade 4 |
1.61045000000026E-05 |
| Grade 3-vs-Grade 4 |
8.423200E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.256180E-01 |
| Normal-vs-ccB subtype |
5.62410000000124E-05 |
| ccA subtype-vs-ccB subtype |
1.078450E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.399700E-03 |
| Normal-vs-N1 |
5.584500E-04 |
| N0-vs-N1 |
1.280450E-01 |
|
|
